Alabama Birth Defect Registry Privacy Laws: Compliance Guide for Prenatal Genetics Offices

Birth Defect Reporting Requirements

Effective date and scope

Effective April 14, 2024, Alabama’s Notifiable Diseases rules designate certain birth defects as reportable conditions. You must report diagnoses made prenatally, at delivery, or up to 12 months of age to support statewide birth defect surveillance and prevention.

Reporting timeline and method

Submit reports within 30 days of the diagnosis or the associated laboratory test. Use the Alabama Department of Public Health’s secure reporting portal or your organization’s enabled electronic case reporting (eCR) feed. Build a standing workflow so cases are queued for submission the moment diagnostic criteria are met.

HIPAA alignment

These reports are required by state law and are permissible under HIPAA’s public health provisions. You do not need patient authorization to submit required data to the health department, but you must safeguard the information you transmit and retain.

Reportable Birth Defects List

Report when a patient is diagnosed with any of the following conditions:

• Anencephalus
• Anotia/microtia
• Atrioventricular septal defect
• Cleft lip and/or palate
• Common truncus arteriosus
• Gastroschisis
• Hypoplastic left heart syndrome
• Limb deficiencies
• Spina bifida
• Tetralogy of Fallot
• Total anomalous pulmonary venous connection
• Transposition of great arteries
• Trisomy 21 (Down syndrome)

Monitor state updates; the State Health Officer may designate additional reportable condition criteria as needed.

Reporting Entities and Responsibilities

Who must report

Each healthcare facility, healthcare provider, or physician who makes the qualifying diagnosis is responsible for reporting. Do not assume another provider or the delivery hospital has filed the case; if you diagnose it, you own the submission.

Operational expectations for prenatal genetics offices

• Designate a reporting lead (often a genetic counselor) to track timelines and data completeness.
• Embed prompts in your EHR to flag reportable conditions at the time of documentation.
• Reconcile monthly against procedure codes, problem lists, and lab results to catch missed cases.
• Retain proof of submission and any ADPH acknowledgments for audit readiness.

Required Data Elements for Reporting

Minimum elements

Your report must include, at minimum:

• Name of the disease or health condition.
• Patient’s full name, date of birth, sex, ethnicity, and race.
• Patient’s address and phone number(s).
• Date of onset, diagnosis, and/or relevant laboratory result.
• Reporter’s name, phone number, and affiliated facility.

Align your intake and EHR templates with these fields to ensure patient demographic data compliance and reduce rework.

Additional elements specific to birth defects

• Mother’s individual identifiable health information and demographics (see next section).
• Clear identification of the specific reportable defect diagnosed.
• Any additional details necessary to confirm accuracy and completeness.

Mother's Identifiable Health Information

Alabama requires the mother’s identifiable health information and demographics with each birth defect report. In practice, this typically includes the mother’s name, date of birth, contact details, address, and other identifiers used to match records accurately.

Apply health information confidentiality principles throughout your workflow. Limit internal access to staff with a role-based need to know, transmit data through secure channels, and retain only what is necessary for legal, clinical, or programmatic obligations. Document how maternal and fetal records are linked to prevent misattribution and ensure longitudinal integrity.

Genetic Data Privacy Act Compliance

Applicability to prenatal genetics offices

Alabama’s Genetic Data Privacy Act primarily governs direct-to-consumer genetic testing companies and excludes HIPAA-covered healthcare providers and their business associates. Most prenatal genetics offices operate as healthcare providers and therefore fall outside this Act’s scope for clinical activities. If you operate a separate consumer-facing genetics service, evaluate that business line independently for applicability.

Core duties if the Act applies to a consumer-facing service

• Obtain express consent for collection, use, retention, and disclosure of genetic data and biological samples.
• Publish clear genetic data disclosure policies explaining access, sharing, security, retention, and deletion.
• Provide consumer rights to access, account deletion, and destruction of biological samples/genetic data within mandated timeframes.
• Do not disclose genetic data to insurers or employers without the consumer’s express written consent.
• Respond to valid legal process for law enforcement requests and maintain appropriate transparency reporting practices.
• Maintain strong deidentification controls when sharing deidentified data.

Interaction with public health reporting

State-mandated birth defect surveillance remains in force. The Act does not restrict or supersede required reporting to ADPH. Continue timely submissions and maintain separate workflows and notices for any direct-to-consumer activities your organization may offer.

Privacy and Security Measures for Patient Records

Technical safeguards aligned to healthcare data encryption standards

• Encrypt ePHI at rest (for example, AES‑256) and in transit (TLS 1.2+), using FIPS 140‑2/140‑3 validated cryptographic modules.
• Harden endpoints and servers; segment networks; enable multi-factor authentication for remote and privileged access.
• Implement continuous audit logging and anomaly detection across EHR, laboratory, and reporting systems.

Administrative and organizational safeguards

• Perform an enterprise risk analysis at least annually and after major changes; track remediation to closure.
• Enforce role-based access, least privilege, and prompt offboarding; conduct focused staff training for genetics workflows.
• Manage vendors with written agreements (e.g., BAAs where applicable); assess security of eCR and integration partners.
• Maintain an incident response and breach notification playbook tested through tabletop exercises.

Program assurance and frameworks

• Map controls to the HIPAA Security Rule and NIST Cybersecurity Framework to evidence maturity.
• Consider HITRUST CSF certification to validate control design and operation across clinical, lab, and reporting systems.

Conclusion

Your path to compliance is clear: identify reportable birth defects promptly, submit required data to ADPH within 30 days, include specified maternal identifiers, and protect all records with robust privacy and security controls. If you also offer consumer genetics services, apply Alabama’s Genetic Data Privacy Act requirements to that line while maintaining uninterrupted public health reporting.

FAQs

What birth defects must be reported under Alabama law?

Report diagnoses of anencephalus; anotia/microtia; atrioventricular septal defect; cleft lip and/or palate; common truncus arteriosus; gastroschisis; hypoplastic left heart syndrome; limb deficiencies; spina bifida; tetralogy of Fallot; total anomalous pulmonary venous connection; transposition of great arteries; and trisomy 21 (Down syndrome). Alabama may update this list, so monitor official notices.

How soon must prenatal genetics offices report diagnosed birth defects?

You must report within 30 days of the diagnosis or associated laboratory test. Build reminders and dashboards so cases never exceed the 30‑day window, and submit as soon as the condition meets reportable criteria.

What data elements are required in birth defect reports?

At minimum, include the condition name; the patient’s name, date of birth, sex, ethnicity, race, address, and phone; the diagnosis/onset and relevant lab dates; and the reporter’s contact information and facility. For birth defects, also include the mother’s identifiable health information and demographics, plus any details needed to ensure accuracy and completeness.

How does the Genetic Data Privacy Act affect reporting?

The Act primarily covers direct‑to‑consumer genetic testing companies and does not apply to HIPAA‑covered healthcare providers. It does not limit required reporting to ADPH. If your organization also runs a consumer‑facing genetics service, implement express consent, clear disclosure policies, consumer rights processes, and restrictions on disclosures to insurers and employers, while continuing timely public health reporting.